You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 266 No. 24, December 25, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Utility of HIV-IgA Immunoblot Assay in the Early Diagnosis of Perinatal HIV Infection

Sheldon Landesman, MD; Barbara Weiblen, MS; Herman Mendez, MD; Anne Willoughby, MD, MPH; James J. Goedert, MD; Arye Rubinstein, MD; Howard Minkoff, MD; Gail Moroso, RN, MPH; Rod Hoff, DSc

JAMA. 1991;266(24):3443-3446.


Abstract

Objective.
—To ascertain the sensitivity, specificity, predictive value, and clinical use of a human immunodeficiency virus (HIV)-IgA immunoblot assay for diagnosing perinatal HIV infection in infants tested at birth to 1 month, 3 months, and 6 months of age.

Design.
—Prospective, longitudinal cohort study of children born to HIVinfected and noninfected women. The HIV-IgA immunoblot assays were performed at birth to 1 month, 3 months, and 6 months of age and compared with the Centers for Disease Control's classification system of HIV infection in the children. Children were followed up for at least 15 months to ensure accuracy of infection status.

Setting.
—Municipal hospital in central Brooklyn, NY, where the prevalence of HIV infection is high.

Patients.
—Serum samples from 58 children, 22 with documented HIV infection, 18 noninfected children born to seropositive women, and 18 children born to noninfected women, were studied.

Main Outcome Measure.
—Diagnosis of HIV infection using the Centers for Disease Control's classification scheme was compared with diagnosis using the HIV-IgA immunoblot assay for children 6 months of age or younger.

Results.
—The HIV-IgA immunoblot assay yielded negative results at 3 and 6 months of age for all 18 infants born to seronegative women; for the 18 seroreverting, noninfected children born to infected women, the assay yielded negative results at 1 month, 3 months, and 6 months of age. The positive predictive value of the assay was 100%—no false-positive results were identified in the 88 serum samples obtained from noninfected infants. For the HIV-infected children, sensitivity was a function of age: one (5.9%) of 17 infants had an assay that yielded positive results at birth to 1 month of age, 13 (62%) of 21 infants had assays that yielded positive results at 3 months of age, and 17 (77%) of 22 infants had assays that yielded positive results at 6 months of age. The presence or absence of symptoms did not affect the sensitivity.

Conclusion.
—The HIV-IgA immunoblot assay can detect a significant proportion of infected children during an early asymptomatic period of their life. This relatively inexpensive, easily standardized assay may allow for institution of therapy before the onset of clinical symptoms.

(JAMA. 1991;266:3443-3446)



Author Affiliations

From the Departments of Medicine (Dr Landesman and Ms Moroso), Pediatrics (Dr Mendez), and Obstetrics and Gynecology (Dr Minkoff), State University of New York Health Science Center at Brooklyn; the Theobald Smith Research Institute, Boston, Mass (Ms Weiblen); the Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development (Dr Willoughby), Viral Epidemiology Branch, National Cancer Institute (Dr Goedert), and Division of AIDS, National Institute of Allergy and Infectious Diseases (Dr Hoff), National Institutes of Health, Bethesda, Md; and the Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY (Dr Rubinstein).


Footnotes

Reprint requests to Department of Medicine, Infectious Diseases Division, State University of New York Health Science Center at Brooklyn, 450 Clarkson Ave, Box 122, Brooklyn, NY 11203-2098 (Dr Landesman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis of Human Immunodeficiency Virus Infection Using an Immunoglobulin E-Based Assay
Fletcher et al.
CVI 2000;7:55-57.
ABSTRACT | FULL TEXT  

A Meta-analytic Evaluation of the Polymerase Chain Reaction for the Diagnosis of HIV Infection in Infants
Owens et al.
JAMA 1996;275:1342-1348.
ABSTRACT  

Disease in children infected with HIV in Abidjan, Cote d'Ivoire
Lucas et al.
BMJ 1996;312:335-338.
ABSTRACT | FULL TEXT  

Use of Methodological Standards in Diagnostic Test Research: Getting Better but Still Not Good
Reid et al.
JAMA 1995;274:645-651.
ABSTRACT  

Human Immunodeficiency Virus-Specific IgA in Infants Born to Human Immunodeficiency Virus-Seropositive Women
Livingston et al.
Arch Pediatr Adolesc Med 1995;149:503-507.
ABSTRACT  

Human Immunodeficiency Virus Infection in Infants During the First 2 Months of Life: Reliable Detection and Evidence of In Utero Transmission
Brandt et al.
Arch Pediatr Adolesc Med 1994;148:250-254.
ABSTRACT  

DETECTING HIV IN NEONATES
JWatch General 1992;1992:2-2.
FULL TEXT  

Advances in Early Diagnosis of Perinatal HIV Infection
Connor
JAMA 1991;266:3474-3475.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.